<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">139413</id>
  <title nil="true"/>
  <common-name>ABSK-012</common-name>
  <description>ABSK-012 belongs to the amino acids, peptides, and analogues, a subclass of carboxylic acids and derivatives within the organic compounds. This compound has the chemical formula C23H26N8O3 and an average molecular weight of 462.51 g/mol.</description>
  <cas>2271209-99-3</cas>
  <pubchem-id nil="true"/>
  <chemical-formula>C23H26N8O3</chemical-formula>
  <weight nil="true"/>
  <appearance nil="true"/>
  <melting-point nil="true"/>
  <boiling-point nil="true"/>
  <density nil="true"/>
  <solubility nil="true"/>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity nil="true"/>
  <metabolism nil="true"/>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity nil="true"/>
  <use-source nil="true"/>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2026-04-14T21:55:08Z</created-at>
  <updated-at type="dateTime">2026-05-14T20:06:06Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia nil="true"/>
  <uniprot-id nil="true"/>
  <kegg-compound-id nil="true"/>
  <omim-id nil="true"/>
  <chebi-id nil="true"/>
  <biocyc-id nil="true"/>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id>DB18035</drugbank-id>
  <pdb-id nil="true"/>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>CN(C(=O)NC1=CC(NC2CC2)=C(C=N1)C#N)C1=CC=C(CN2CCN(C)CC2=O)C(C=O)=N1</moldb-smiles>
  <moldb-formula>C23H26N8O3</moldb-formula>
  <moldb-inchi>InChI=1S/C23H26N8O3/c1-29-7-8-31(22(33)13-29)12-15-3-6-21(27-19(15)14-32)30(2)23(34)28-20-9-18(26-17-4-5-17)16(10-24)11-25-20/h3,6,9,11,14,17H,4-5,7-8,12-13H2,1-2H3,(H2,25,26,28,34)</moldb-inchi>
  <moldb-inchikey>MXHSTECIDQMETN-UHFFFAOYSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal">462.514</moldb-average-mass>
  <moldb-mono-mass type="decimal">462.212786729</moldb-mono-mass>
  <origin nil="true"/>
  <state nil="true"/>
  <logp>0.81</logp>
  <hmdb-id nil="true"/>
  <chembl-id nil="true"/>
  <chemspider-id nil="true"/>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference nil="true"/>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM135306</chemdb-id>
  <dsstox-id nil="true"/>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id nil="true"/>
  <iupac>3-[5-cyano-4-(cyclopropylamino)pyridin-2-yl]-1-{6-formyl-5-[(4-methyl-2-oxopiperazin-1-yl)methyl]pyridin-2-yl}-1-methylurea</iupac>
  <moldb-polar-surface-area nil="true"/>
  <moldb-refractivity nil="true"/>
  <moldb-polarizability nil="true"/>
  <moldb-rotatable-bond-count nil="true"/>
  <moldb-acceptor-count nil="true"/>
  <moldb-donor-count nil="true"/>
  <moldb-pka-strongest-acidic nil="true"/>
  <moldb-pka-strongest-basic nil="true"/>
  <moldb-physiological-charge nil="true"/>
  <moldb-number-of-rings nil="true"/>
  <moldb-alogps-logp nil="true"/>
  <moldb-alogps-logs nil="true"/>
  <moldb-alogps-solubility nil="true"/>
  <kingdom>Organic compounds</kingdom>
  <superklass>Organic acids and derivatives</superklass>
  <klass>Carboxylic acids and derivatives</klass>
  <subklass>Amino acids, peptides, and analogues</subklass>
  <paper-count type="integer">0</paper-count>
  <sync-id>CED0141828</sync-id>
  <structure-inchikey>MXHSTECIDQMETN-UHFFFAOYSA-N</structure-inchikey>
  <structure-fingerprint>420000000002002000800000000000002000000000000040010000010020000000000001000020004000000140002000000000000000000000000000000000000800000000080000000000000000800020002020000200000000000010000000440202010000800000000000104000000000020100000000000000000800100000000049000002401000000000814080100080000000000080000020000000000000000204000004000000088000000000000000080000008000000000000100000000000004000000000020000000000000000000000000040200040000000000009000000001020440000000000600000020000000000000000000000002</structure-fingerprint>
  <structure-pattern-fingerprint>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</structure-pattern-fingerprint>
  <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAiAAAAJQAAAIABBgBgAAAAAQMHACgAAAAD
AwYAKAAAAAMECAAoAAAAAwIHAGgAAAADAgEGQCgAAAADBAZAaAAAAAMDAQZA
KAAAAAMEBwBoAAAAAwIBBgBgAAAAAwEGAGAAAAACAgYAYAAAAAICBkAoAAAA
AwQGQGgAAAADAwEHQCgAAAADAwYAKAAAAAIEBwAoAAAAAgMGQCgAAAADBAZA
aAAAAAMDAQZAaAAAAAMDAQZAKAAAAAMEBgBgAAAAAgIHACgAAAADAwYAYAAA
AAICBgBgAAAAAgIHACAAAAADBgBgAAAAAQMGAGAAAAACAgYAKAAAAAMECAAo
AAAAAwIGQCgAAAADBAYAaAAAAAMDAQgAKAAAAAMCB0AoAAAAAwMLAAEAAQIg
AgMoAgIEIAQFIAUGaAwGB2gMBwggCAkACQoACgsABwxoDAwNaAwNDmgMDA8g
DxAoAwERIBESaAwSE2gMExRoDBQVABUWABYXABcYABgZABkaABkbABscABwd
KAIUHmgMHh8gHyAoAh4haAwOBWgMIRFoDAsJABwWIEIEAAAABgYHDA0OBQMK
CQsGEhMUHiERBhcYGRscFhcEAAAAAAAAABY=
</structure-pickle>
  <structure-indexed-at type="dateTime">2026-09-19T04:50:58Z</structure-indexed-at>
</compound>
